Coherence Bio Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
2
Coherence Bio General Information
Description
Developer of a laboratory run infrastructure designed to execute controlled biological workflows and capture reproducible experimental data for AI-driven research. The company's platform offers a modular benchtop system that performs cell and organoid workflows in a sealed and programmable environment while capturing structured provenance data, enabling early-stage AI biotechnology companies and contract research organizations to reduce experimental variability and generate consistent biological evidence for model development.
Contact Information
Website
www.coherencebio.comCorporate Office
- 4th Floor, Number 6, Zhiyuan 3rd Road.
- Beitou District
- Taipei, 112-02
- Taiwan
Corporate Office
- 4th Floor, Number 6, Zhiyuan 3rd Road.
- Beitou District
- Taipei, 112-02
- Taiwan
Coherence Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Accelerator/Incubator | 22-May-2025 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 01-Dec-2024 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 20-Mar-2024 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 27-Apr-2021 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Coherence Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Coherence Bio Patents
Coherence Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260141521-A1 | Biological sample analysis system and biological sample analysis method | Pending | 20-Nov-2024 |
Coherence Bio Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| UC Berkeley School of Public Health Innovation Accelerator Program | Accelerator/Incubator | |||
| VENTURE+ | Venture Capital | Minority |
Coherence Bio FAQs
-
When was Coherence Bio founded?
Coherence Bio was founded in 2021.
-
Where is Coherence Bio headquartered?
Coherence Bio is headquartered in Taipei, Taiwan.
-
What industry is Coherence Bio in?
Coherence Bio’s primary industry is Enterprise Systems (Healthcare).
-
Is Coherence Bio a private or public company?
Coherence Bio is a Private company.
-
What is Coherence Bio’s current revenue?
The current revenue for Coherence Bio is .
-
Who are Coherence Bio’s investors?
UC Berkeley School of Public Health Innovation Accelerator Program and VENTURE+ have invested in Coherence Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
